EVO
HYBRID
REGENERATIVE THERAPY
FOR ERECTILE DYSFUNCTION
BREAKTHROUGHTHERAPY
Did you know? Erectile dysfunction will happen to 33% of men by age 50, and 42% by age 60. 18 million American males suffer from ED, and worldwide ED will affect 322 million men by the year 2025. Erectile dysfunction (impotence) is the inability to get and keep an erection firm enough for sex.
Introducing the Evo Hybrid™ Regenerative Therapy
for Erectile Dysfunction
RESTORATIONTREATMENTS
Regenerative medicine has developed extensively in the past few decades and preclinical trials have emphasized the benefit of tissue engineering for the restoration of erectile function. The identification of a large population of “difficult-to-treat” patients has triggered researchers to identify novel treatment approaches, which focus on cure and restoration of the underlying cause of ED.
New regenerative therapies have shown promising outcomes in restoring the structure and function of erectile tissues. Such therapies aim to restore the erectile function by regerating damaged nerves and muscles, increasing blood flow through angiogenesis, as well as regulating the expressions of growth factors.
THE ANSWERTO ERECTILE DYSFUNCTION
ED is the most common sexual disorder reported by men to their health-care providers and the most investigated male sexual dysfunction. Having erection trouble from time to time isn't necessarily a cause for concern. But if erectile dysfunction is an ongoing issue, it can cause stress, affect your self-confidence and contribute to relationship problems.
To get and keep an erection, blood needs to travel in and out of your penis, and if it can't, this can mean that one or more of your blood vessels have narrowed or are blocked. Currently, the treatment of ED focuses on 'symptomatic relief', therefore it tends to provide temporary relief rather than providing a cure or reversing the cause. Until now!
Connect with Evolutionary Biologics Inc.